Biogen to acquire Apellis Pharmaceuticals for $5.6B, adding C3 therapies to portfolio

admin_news admin_news
Mar 31, 2026 - 22:00
0 0
Biogen to acquire Apellis Pharmaceuticals for $5.6B, adding C3 therapies to portfolio
Read More